Teladoc Health, Inc. (LON:0LDR)
London · Delayed Price · Currency is GBP · Price in USD 6.13
+0.08 (1.32%)
Jan 21, 2026, 5:08 PM GMT
Teladoc Health Market Cap
Teladoc Health has a market cap or net worth of 800.08 million as of January 21, 2026. Its market cap has decreased by -39.60% in one year.
Market Cap
800.08M
Enterprise Value
1.03B
Revenue
1.88B
Ranking
n/a
PE Ratio
n/a
Stock Price
6.13
Market Cap Chart
Since July 1, 2015, Teladoc Health's market cap has increased from 675.25M to 800.08M, an increase of 18.49%. That is a compound annual growth rate of 1.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 800.08M | -13.32% |
| Dec 31, 2025 | 923.04M | -26.16% |
| Dec 31, 2024 | 1.25B | -55.37% |
| Dec 29, 2023 | 2.80B | -11.87% |
| Dec 30, 2022 | 3.18B | -70.72% |
| Dec 31, 2021 | 10.86B | -48.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.42B |
| GSK plc | 72.86B |
| Haleon | 32.41B |
| Smith & Nephew | 10.28B |
| Convatec Group | 4.51B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 2.00B |
| Genus | 1.90B |